狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
            中級(jí)會(huì)員 | 第10年

            15012456311

            新到托法替尼雜質(zhì)一批 申報(bào)可用提供圖譜

            時(shí)間:2016-6-17閱讀:2057
            分享:

            深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司新到托法替尼雜質(zhì)(托法替布雜質(zhì))一批,申報(bào)可用,隨貨提供COA證書,氫譜,質(zhì)譜及HPLC,純度符合申報(bào)要求,質(zhì)量保證。更多雜質(zhì)對(duì)照品,歡迎進(jìn)入我公司展臺(tái)查詢。

             

            另有托法替尼原研藥出售:

            托法替尼Xeljanz原研藥/原研制劑

            商品名(英): Xeljanz

            英文名:tofacitinib
            通用名:托法替尼
            規(guī)格:5mg 60片一瓶 
            類型:口服
            制藥公司:輝瑞
            上市時(shí)間(美國(guó)FDA批準(zhǔn)):2012/11/6
            用途:僅供科研實(shí)驗(yàn)使用。
            適應(yīng)癥:對(duì)氨甲喋呤治療應(yīng)答不充分或不耐受的中至重度活動(dòng)性類風(fēng)濕關(guān)節(jié)炎(RA)成人患者。

             

            附:托法替尼雜質(zhì)列表:

            Tofacitinib

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 1

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-1H-indol-4-amine

            Tofacitinib Impurity 2

            2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 3

            3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 4

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 5

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxoprop*

            Tofacitinib Impurity 6

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid

            Tofacitinib Impurity 7

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 8

            N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

            Tofacitinib Impurity 9

            (3R,4S)-Tofacitinib with(3S,4R)-Tofacitinib

            3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1)

            Tofacitinib Impurity 10

            (3S,4S)-Tofacitinib

            3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 11

            (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 12

            (3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 13

            (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 14

            (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 15

            3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 16

            (3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde

            Tofacitinib Impurity 17

            N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 18

            3,3'-((3R,3'R,4R,4'R)-3,3'-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile)

            Tofacitinib Impurity 19

            3-(4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 20

            3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 21

            N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide

            Tofacitinib Impurity 22

            (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine hydrochloride

            Tofacitinib Impurity 23

            (3R,4R)-N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine

            Tofacitinib Impurity 24

            N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

            Tofacitinib Impurity 25

            1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone

            Tofacitinib Impurity 26

            N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-((3S,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (1:1)

            Tofacitinib Impurity 27

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            會(huì)員登錄

            ×

            請(qǐng)輸入賬號(hào)

            請(qǐng)輸入密碼

            =

            請(qǐng)輸驗(yàn)證碼

            收藏該商鋪

            X
            該信息已收藏!
            標(biāo)簽:
            保存成功

            (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

            常用:

            提示

            X
            您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
            撥打電話
            在線留言